Jornal de Diabetes e Prática Clínica

Abstrato

Bariatric Surgery and its Clinical Applications in China: Single Center Experience

Wei FX, Zhang YC, Deng HY and Wang ZY

Type 2 Diabetes Mellitus (T2DM) as a common chronic metabolism disease, its prevalence is creasing currently, especially in China. For its treatment, hypoglycemic drugs and insulin are commonly used besides of physical exercise and diet adjustment. Meanwhile, bariatric surgery is emerging as a promising option for severely T2DM specifically combined with obesity. To present our experience from a single center on diabetes surgery for selected patients mainly based on the guidance from Chinese experts. A short communication and literature review mainly based on the Chinese population was performed. In our center, all of the uncontrolled and intolerable T2DM patients after comprehensive no-surgical treatment are potential for bariatric surgery, especially Roux-en-Y Gastric Bypass surgery (RYGB). For T2DM patients with a medical history less than 15 years, pre-operative evaluation mainly included pancreatic beta-cell reserve function and C-peptide section. Also, operative metabolism monitor is necessary for efficacy determination. The choice of bariatric surgery in our center is mainly RYGB, and proper patient selection based on pre-operative evaluation is essential for confirmed treatment efficacy by a long-term postoperative monitoring.